Ticker Scorecard - GNPX Basics Company: Genprex, Inc. IPO Date: March 29, 2018 Sector: Healthcare Industry: Biotech Market Cap: $7.9M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 4.92% Avg Daily Range (30 D): $0.04 | 3.82% Avg Daily Range (90 D): $0.10 | 8.80% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): .56M Avg Daily Volume (90 D): 5.45M Trade Size Avg Trade Size (Sh.): 89 Avg Trade Size (Sh.) (30 D): 415 Avg Trade Size (Sh.) (90 D): 316 Institutional Trades Total Inst.Trades: 30 Avg Inst. Trade: $1.54M Avg Inst. Trade (30 D): $1.18M Avg Inst. Trade (90 D): $1.18M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.5M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 23.79K     News Sep 9, 2024 @ 1:29 PM Genprex Collaborators to Present Positive Preclini... Source: Prnewswire Apr 4, 2024 @ 12:57 PM Genprex (GNPX) Expands SCLC Study of Key Candidate... Source: Zacks Equity Research Mar 6, 2024 @ 6:54 PM Why United Natural Foods Shares Are Trading Lower ... Source: Avi Kapoor Jan 31, 2024 @ 7:26 PM Dow Turns Lower; Federal Reserve Keeps Rates Uncha... Source: Avi Kapoor Jan 31, 2024 @ 6:18 PM Why AMD Shares Are Trading Lower? Here Are Other S... Source: Avi Kapoor Financials   TTM Q3 2024 Q2 2024 Basic EPS $-11.61 $-1.23 $-3 Diluted EPS Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -22.71M $ -4.32M $ -6.5M Operating Income / Loss $ -22.83M $ -4.32M $ -6.52M Cost of Revenue $ $ $ Net Cash Flow $ -10.22M $ -.97M $ -5.76M PE Ratio     Splits Feb 02, 2024:   40:1